US Medical Costs Spark Online Debate After Comparison With India’s Healthcare Expenses

Summary:
A recent comparison of medicine costs has reignited debate over the affordability of healthcare in the United States after an Indian resident shared how identical medicines manufactured in India cost many times more in the US, even with health insurance. The experience, along with a viral social media post comparing cancer drug prices in the two countries, has highlighted the significant gap in treatment costs, long waiting times, and consultation fees in the US. These discussions have prompted renewed attention to the high cost of American healthcare and explain why many NRIs continue to rely on India for medicines and medical treatment whenever possible. 

The high cost of healthcare in the United States has once again become a topic of discussion, with many people questioning why medicines that are relatively inexpensive in India are sold at significantly higher prices in the US.

In a post shared on X on July 5, Adhir Sinha, who recently relocated to the United States, described his family’s experience. He said his wife had been suffering from a serious respiratory illness when they left India, and her condition improved after taking medicines they had brought with them. Once those medicines were exhausted, they tried to obtain the same treatment in Seattle.

According to Sinha, they had to wait a week before securing a telephonic consultation with a doctor. After receiving the prescription, they were informed that the medicines could be collected from a pharmacy, but the medicines were initially out of stock. He said they finally received them five days later and discovered that the medicines were manufactured by Cipla and labelled “Made in India.” Even after receiving a 50% discount through US medical insurance, the family still paid around ₹21,000, suggesting that medicines priced at about ₹2,500 in India would cost nearly ₹42,000 in the US without insurance.

Sinha also pointed out that it took 12 days to obtain medicines that are commonly available at pharmacies across India. In addition to the medication expenses, the doctor’s consultation reportedly cost $283, or approximately ₹23,000.

The experience has renewed attention on the US healthcare system, which is regarded as one of the world’s costliest. Despite accounting for nearly 18% of the country’s GDP, concerns continue over affordability, medical debt, and overall public health outcomes.

Reflecting on the comparison, Sinha said that people in India should appreciate the comparatively affordable access to healthcare services available in the country.

A similar discussion recently emerged on Instagram, where a user named @spicygori compared the branded cancer medicine Revlimid (lenalidomide) with its Indian generic alternatives. Referring to her aunt’s cancer treatment, she claimed that a single Revlimid tablet costs around $900 in the US, or nearly ₹85,000, whereas generic versions in India are available for approximately ₹35 to ₹300. Her video quickly attracted widespread attention, receiving more than 1.7 million views within four days.

These examples have fuelled fresh debate over the high cost of healthcare in the United States and why many non-resident Indians (NRIs) continue to rely on purchasing medicines and receiving treatment from India whenever possible.